Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for windebank

Edit search filters
  1. A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis

    Rochester, MN

  2. A Study of the Safety of Mesenchymal Stem Cells for Treatment of One Patient with Amyotrophic Lateral Sclerosis (ALS)

    Rochester, MN

  3. Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients

    Rochester, MN

  4. A Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial

    Rochester, MN

  5. A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS)

    Rochester, MN

  6. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS

    Rochester, MN


Mayo Clinic Footer